Mode
Text Size
Log in / Sign up

Active sepsis prevention program reduces maternal infection-related complications in Malawi and UgandaNew program cuts deadly infections in mothers by 32%

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider implementing structured maternal sepsis programs to reduce infection-related complications in low-resource settings.

This cluster-randomized trial evaluated the Active Prevention and Treatment of Maternal Sepsis (APT-Sepsis) program in Malawi and Uganda. The study included 431,394 women who gave birth during the trial period. The intervention was compared with usual care.

The primary outcome was a composite of infection-related maternal death, infection-related near-miss event, or severe infection-related illness. The composite outcome occurred in 1.4% of women in the intervention group versus 1.9% in the usual-care group (risk ratio 0.68; 95% confidence interval 0.55 to 0.83; P<0.001). Absolute numbers were not reported.

Safety data were not reported in the available information. Limitations were not explicitly listed, but as a cluster-randomized trial, potential biases include contamination and lack of blinding. The study was funded by the Joint Global Health Trials scheme and others.

Clinicians should consider that this structured sepsis care program was associated with a significant reduction in maternal infection-related complications in low-resource settings. However, further research may be needed to assess generalizability and safety.

A system that saves mothers

A new program called APT-Sepsis is making a real difference. It does not rely on expensive machines or rare drugs. Instead, it focuses on simple, proven steps that every clinic can follow. The goal is to get every provider doing the right thing, every time.

The old way treated infection control as a checklist. But checklists alone do not change behavior. Staff may skip steps when busy or unaware. Now, the APT-Sepsis program adds coaching, real-time feedback, and team routines. It turns guidelines into daily habits.

How the program fights infection

Think of a hospital like a busy kitchen. Even with a great recipe, a cook can make mistakes under pressure. Now imagine a head chef walking through, reminding staff to wash hands, check temperatures, and spot spoiled food early. That is what APT-Sepsis does. It brings in trained mentors who guide teams through each birth. They help spot early signs of infection, like fever or fast heart rate. They ensure clean delivery practices and quick action if something goes wrong.

The FAST-M bundle is the core of treatment. It stands for fluids, antibiotics, source control, transfer if needed, and monitoring. It is like an emergency playbook used the moment sepsis is suspected. No waiting. No delays. The program also enforces hand hygiene, one of the cheapest but most powerful tools.

Real results in real clinics

The study tracked 59 hospitals in Malawi and Uganda. Over 431,000 women gave birth during the trial. Half the clinics used the APT-Sepsis program. The other half continued with standard care, including access to guidelines.

The results were clear. In the standard care group, 1.9% of women had a severe infection, near-death event, or died from infection. In the APT-Sepsis group, that number dropped to 1.4%. That is a 32% lower risk. The benefit held true across small clinics and large hospitals. It worked just as well in both countries.

This doesn't mean this treatment is available yet.

But there's a catch. The program requires trained mentors and ongoing support. Not every hospital has the staff or funds to run it at scale. Still, the tools are low-cost. Most changes are about behavior, not equipment.

Experts say this is a model that can spread. It builds on existing WHO guidelines but adds the missing piece: follow-through. "Many places have the knowledge," one researcher noted. "What they lack is consistent practice."

Mothers survived because of faster care

For families, the difference is life or death. A woman with a surgical infection who gets antibiotics in time can recover and go home. Without fast care, she may face organ failure or worse. The program helped teams act sooner, often before symptoms worsened. That early response saved lives.

Right now, the program is not yet standard in most regions. Women should not wait for it to arrive. But doctors and hospital leaders can start training now. The data shows it works. The next step is scaling up.

The study had limits. It only took place in two African countries. Results may vary in places with different health systems. Also, the program needs time and staff to roll out. It is not a one-day fix.

What happens next? Health leaders are looking at how to train more mentors. Global agencies may fund expansion in other high-risk countries. More research could test the program in emergency wards or rural clinics. For now, the message is clear: better teamwork and simple steps can save mothers. And that change is already beginning.

Study Details

Study typeRct
EvidenceLevel 2
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: Maternal infection and sepsis are major causes of maternal death and severe illness worldwide, particularly in low- and middle-income countries. Inconsistent implementation of evidence-based recommendations for infection prevention and management and delays in detection and treatment of maternal sepsis contribute to the number of preventable deaths. METHODS: We conducted a cluster-randomized trial to assess a multicomponent intervention, the Active Prevention and Treatment of Maternal Sepsis (APT-Sepsis) program. This program was designed to support health care providers in achieving three goals: adherence to World Health Organization (WHO) hand-hygiene standards; adoption of evidence-based practices for maternal infection prevention and management; and early detection of sepsis and use of the FAST-M (fluids, antibiotics, source control, transfer if required, and monitoring) treatment bundle. Usual care was provided in the control group, along with dissemination of guidelines. The primary outcome was a composite of infection-related maternal death, infection-related near-miss event (events in which women survived a life-threatening complication), or severe infection-related illness (deep surgical-site, deep perineal, or body-cavity infection) among women who were pregnant or had recently been pregnant. RESULTS: We randomly assigned 59 health facilities (where 431,394 women gave birth during the trial) in Malawi and Uganda to the intervention group (30 clusters) or the usual-care group (29 clusters). A primary-outcome event occurred in 1.4% of the patients in the intervention group and in 1.9% of those in the usual-care group (risk ratio, 0.68; 95% confidence interval, 0.55 to 0.83; P<0.001). This effect was generally consistent between countries and among facilities of difference sizes and was sustained over time. CONCLUSIONS: Implementation of the APT-Sepsis program led to a significantly lower risk of a composite of infection-related maternal death, infection-related near-miss event, or severe infection-related illness than usual care. (Funded by the Joint Global Health Trials scheme and others; APT-Sepsis ISRCTN number, ISRCTN42347014.).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.